Navigation Links
ACTUS Appoints New Members to Its Management Team
Date:10/1/2013

Oro Valley, AZ (PRWEB) October 01, 2013

ACTUS Biotechnologies has recently added four highly experienced industry professionals to its management team, further broadening the capabilities of its existing team, and adding more than a century of experience to the organization. The ACTUS Biotechnologies management team serves in a duplicate role in each of the accelerator’s subsidiaries, Convoy Therapeutics and EnduRx Pharmaceuticals. These personnel round out a team that already includes executive and senior management in Regulatory Affairs, Quality Assurance, and Business Development.

Dr. Deborah Slee has joined ACTUS as the Vice President of Research & Development, overseeing a team of fifteen personnel from various disciplines serving in full-time and consulting capacities within the organization. She is also leading efforts at the ACTUS laboratory being established at the Janseen incubator in La Jolla, CA. Dr. Slee’s career includes more than twenty years of industry experience in a variety of therapeutic areas leading development efforts. She is a co-founder of both Aspyrian Therapeutics and CendR Therapeutics and previously led efforts at both Ontogen and Neurocrine Biosciences. Dr. Slee received her Ph.D. from the University of Exeter and performed post-doctoral research at The Scripps Research Institute in La Jolla, CA.

Also joining the ACTUS Research & Development team is Dr. Sarah Hudson, as the Director of Project Management. With more than ten years of experience in research and development and project management in biopharmaceutical companies, including Neurocrine Biosciences, Exelixis, and most recently CovX, a division of Pfizer, she brings an outstanding track record to the ACTUS team. Dr. Hudson earned her Ph.D. at the University of Bristol and performed her post-doctoral work at Neurocrine Biosciences.

Mr. Brandon French, an accomplished healthcare operations and business dev
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Immune Design Appoints Stephen R. Brady Chief Business Officer
2. DiaVacs, Inc. Appoints Orville Kolterman, M.D. As Chief Medical Officer
3. Sanomedics International Holdings, Inc. appoints new Chairman of the Board and installs new Director of Business Development.
4. Solulink Appoints Life Science Industry Veteran Jack Ball as Chief Executive Officer
5. Cold Spring Harbor Laboratory Appoints Teri F. Willey to Accelerate Commercialization Efforts
6. Senn Chemicals Appoints New Chief Executive Officer
7. Novelda Appoints Alf-Egil Bogen as Chief Executive Officer to Lead the Company to the Next Level
8. Creabilis Appoints Professor Gil Yosipovitch and Professor Praveen Anand to its Scientific Advisory Board
9. Alexander Proudfoot Appoints Executive Vice President for Life Sciences
10. KemPharm, Inc. Appoints Gordon K. "Rusty" Johnson as Chief Operating Officer and Chief Financial Officer
11. KaloBios Appoints Donald R. Joseph as Chief Legal Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... , Not for release, publication or ... any jurisdiction where to do so would constitute a violation ... plc ("Shire" or the "Company") (LSE: SHP, NASDAQ: ... it has held a meeting with representatives of AbbVie. ... prior agreement or approval of AbbVie. A further ...
(Date:7/11/2014)... BCC Research ( http://www.bccresearch.com ) reveals ... REACTION (PCR) TECHNOLOGY: GLOBAL MARKETS , the global market ... $140 billion in 2013. This is estimated to grow ... annual growth rate (CAGR) of 28.6%. , New digital ... exciting possibilities within the broader PCR field. The opportunities ...
(Date:7/11/2014)... ON , July 11, 2014 /CNW/ - Sunovion ... approved APTIOM TM (eslicarbazepine acetate) for use as ... seizures in patients with epilepsy who are not satisfactorily ... indicated for use in patients under 18 years of ... most common neurological disorders and according to Epilepsy Canada, ...
(Date:7/11/2014)... Scottsdale, AZ (PRWEB) July 11, 2014 ... medicine device company specializing in the soft tissue ... SureLock All-Suture Anchor System for surgeries involving the ... predictable fixation through a novel, inserter-controlled deployment method. ... lead to partial deployment, anchor pull-out, or anchor ...
Breaking Biology Technology:Shire plc - Statement re: Media Speculation 2Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 2Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 3Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 2Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 3Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 4Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery 2Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery 3
... developed a model that will allow them to simulate how ... model enables further research that may provide insight into the ... published each year that use the rat whisker system as ... move their whiskers rhythmically against objects to explore the environment ...
... Precision Therapeutics, Inc. announced that the launch of ... the personalization of cancer treatments.  BioSpeciFx® is composed ... clinically useful biomarker tests that identify critical molecular ... information generated by BioSpeciFx® in combination with Precision,s ...
... April 7, 2011 The Center for Business Intelligence (CBI) ... American Red Cross in support of the relief efforts in ... personal contributions to the fund while the organization matched employee ... and generosity CBI employees have displayed to help a nation ...
Cached Biology Technology:New model of whiskers provides insight into sense of touch 2New model of whiskers provides insight into sense of touch 3Precision Therapeutics Announces New Tumor Profiling Product to Augment Utility of ChemoFx® and Further Personalize Cancer Treatment 2The Center for Business Intelligence Donates to the American Red Cross, Matching Employee Contributions for Disaster Relief in Japan 2
(Date:7/10/2014)... -- Fingerprint Cards, (FPC,s) new mobile touch sensor ... Chinese Top 5 smartphone OEM has selected FPC1021 for a ... October 2014.   FPC is proud to announce ... has a planned date for the start of mass production ... phone of 3 million units. The Chinese OEM wants to ...
(Date:7/10/2014)... Fingerprint Cards, (FPC,s) new ... (DW). An Asian OEM has selected FPC1021 for a flagship ... August 2014.   FPC is proud to announce ... planned date for start of mass production in August 2014. ... 5M, for delivery in the first half of July. The ...
(Date:7/10/2014)... 9, 2014 The widespread adoption of ... part by meaningful use and related federal programs, ... with laboratory information. Now, more than ever, pathologists ... clinical informatics in order to deliver high quality ... the educational needs of pathologists in this evolving ...
Breaking Biology News(10 mins):FPC Wins DW for 1021 Touch Sensor for Flagship Smartphone from Chinese Top 5 Smartphone OEM 2FPC Wins DW and Initial Ramp Order for FPC1021 Touch Sensor for Flagship Smartphone from Asian OEM 2New Clinical Informatics Curriculum Prepares Future Pathologists 2New Clinical Informatics Curriculum Prepares Future Pathologists 3New Clinical Informatics Curriculum Prepares Future Pathologists 4
... pollen next, you have to literally think like one. , ... are more likely to stick with it rather than invest ... student at the University of Wisconsin-Milwaukee (UWM). , Flanigan ... bees as they gather pollen ?which plant species the bees ...
... five-year, $1 million grant from the National Cancer Institute, a ... improve the effectiveness of a drug that he developed ... Waldemar Debinski, M.D., Ph.D., pioneered a method to destroy cells ... The drug is currently being tested in clinical trials and ...
... research team led by scientists at the Broad Institute of ... kind of genetic "roadmap" that can connect human diseases with ... new drugs work in human cells. Called the "Connectivity Map," ... September 29 issue of Science and in separate publications in ...
Cached Biology News:Researchers find that bumblebees' flower choice matters 2Researchers find that bumblebees' flower choice matters 3Researchers find that bumblebees' flower choice matters 4Scientist works to improve treatment for brain tumors 2Genetic 'roadmap' charts links between drugs and human disease 2Genetic 'roadmap' charts links between drugs and human disease 3
Bovine Brain Microvascular Endothelial Cells (BBMVEC) (>500,000 cells)...
... Rabbit polyclonal to Peroxiredoxin 1 ... peroxidase family, whose mammalian members have ... proliferation, differentiation, and apoptosis. Many isoforms ... to the amino acid sequence homology, ...
Spectrolyse (pL) PAI kit is a two-stage indirect enzymatic assay for the quantitative determination of Plasminogen Activator Inhibitor (PAI-1) activity in plasma. Sample Type: plasma...
NAK/TBK1 (CT) Affinity Purified Polyclonal Antibody...
Biology Products: